
Donna J. Ricks
Examiner (ID: 140, Phone: (571)270-7532 , Office: P/2612 )
| Most Active Art Unit | 2612 |
| Art Unit(s) | 2679, 2612, 2618, 2628, 2677 |
| Total Applications | 602 |
| Issued Applications | 434 |
| Pending Applications | 57 |
| Abandoned Applications | 118 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17419539
[patent_doc_number] => 11252965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => RNAi insecticide materials and methods
[patent_app_type] => utility
[patent_app_number] => 16/316847
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17304
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316847 | RNAi insecticide materials and methods | Jul 12, 2017 | Issued |
Array
(
[id] => 14897547
[patent_doc_number] => 20190292539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => METHOD FOR MODIFYING GENES
[patent_app_type] => utility
[patent_app_number] => 16/316764
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16316764
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/316764 | Method for modifying genes | Jul 12, 2017 | Issued |
Array
(
[id] => 14963631
[patent_doc_number] => 20190309294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => PROCESS OF DELIVERING SMALL RNAS TO SPERM
[patent_app_type] => utility
[patent_app_number] => 16/315004
[patent_app_country] => US
[patent_app_date] => 2017-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -135
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315004
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315004 | Process of delivering small RNAs to sperm | Jul 11, 2017 | Issued |
Array
(
[id] => 17280923
[patent_doc_number] => 11197936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Methods and compositions for treatment of disorders and diseases involving RDH12
[patent_app_type] => utility
[patent_app_number] => 16/314179
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 19692
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314179 | Methods and compositions for treatment of disorders and diseases involving RDH12 | Jul 6, 2017 | Issued |
Array
(
[id] => 15210461
[patent_doc_number] => 20190367917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => DIAGNOSING COL6-RELATED DISORDERS AND METHODS FOR TREATING SAME
[patent_app_type] => utility
[patent_app_number] => 16/315278
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315278
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315278 | Diagnosing COL6-related disorders and methods for treating same | Jul 4, 2017 | Issued |
Array
(
[id] => 12157289
[patent_doc_number] => 20180028554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'Oligomers Having Bicyclic Scaffold Moeities'
[patent_app_type] => utility
[patent_app_number] => 15/642270
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 43695
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15642270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/642270 | Oligomers Having Bicyclic Scaffold Moeities | Jul 4, 2017 | Abandoned |
Array
(
[id] => 14747365
[patent_doc_number] => 20190256856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHODS OF MODULATING MELANOSOME PH AND MELANIN LEVEL IN CELLS
[patent_app_type] => utility
[patent_app_number] => 16/314203
[patent_app_country] => US
[patent_app_date] => 2017-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16314203
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/314203 | Methods of modulating melanosome pH and melanin level in cells | Jun 29, 2017 | Issued |
Array
(
[id] => 11994207
[patent_doc_number] => 20170298362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'ANTI-TUMOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/636952
[patent_app_country] => US
[patent_app_date] => 2017-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15832
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636952 | ANTI-TUMOR THERAPY | Jun 28, 2017 | Abandoned |
Array
(
[id] => 12119115
[patent_doc_number] => 20180002702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION'
[patent_app_type] => utility
[patent_app_number] => 15/636528
[patent_app_country] => US
[patent_app_date] => 2017-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 20612
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15636528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/636528 | METHODS AND COMPOSITIONS FOR TREATING MALIGNANT TUMORS ASSOCIATED WITH KRAS MUTATION | Jun 27, 2017 | Abandoned |
Array
(
[id] => 17075117
[patent_doc_number] => 11111503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Method for expressing protein gene in response to expression of miRNA
[patent_app_type] => utility
[patent_app_number] => 16/313322
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10902
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313322 | Method for expressing protein gene in response to expression of miRNA | Jun 26, 2017 | Issued |
Array
(
[id] => 15020945
[patent_doc_number] => 20190321477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => METHODS AND COMPOSITIONS RELATED TO CHITOSAN-DERIVED NANOPARTICLE-MEDIATED CRISPR/CAS9 DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/313255
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313255
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313255 | METHODS AND COMPOSITIONS RELATED TO CHITOSAN-DERIVED NANOPARTICLE-MEDIATED CRISPR/CAS9 DELIVERY | Jun 26, 2017 | Abandoned |
Array
(
[id] => 13703287
[patent_doc_number] => 20170362598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => ANTICANCER THERAPEUTIC INTERVENTION
[patent_app_type] => utility
[patent_app_number] => 15/622859
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/622859 | Anticancer therapeutic intervention | Jun 13, 2017 | Issued |
Array
(
[id] => 16399153
[patent_doc_number] => 20200340011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => RECOMBINANT INSECT VECTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/308076
[patent_app_country] => US
[patent_app_date] => 2017-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308076 | RECOMBINANT INSECT VECTORS AND METHODS OF USE | Jun 11, 2017 | Abandoned |
Array
(
[id] => 14277913
[patent_doc_number] => 20190136241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => APTAMER-BASED ANALYTE ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/306485
[patent_app_country] => US
[patent_app_date] => 2017-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306485
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306485 | APTAMER-BASED ANALYTE ASSAYS | Jun 4, 2017 | Abandoned |
Array
(
[id] => 15102755
[patent_doc_number] => 10472681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => miRNA-based universal screening test (UST)
[patent_app_type] => utility
[patent_app_number] => 15/606747
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 148
[patent_no_of_words] => 24856
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606747
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606747 | miRNA-based universal screening test (UST) | May 25, 2017 | Issued |
Array
(
[id] => 12656866
[patent_doc_number] => 20180110788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 15/604993
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15604993
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/604993 | METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS | May 24, 2017 | Abandoned |
Array
(
[id] => 16843122
[patent_doc_number] => 11015196
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases
[patent_app_type] => utility
[patent_app_number] => 16/302940
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 19
[patent_no_of_words] => 29363
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302940 | Using microRNAs to control activation status of hepatic stellate cells and to prevent fibrosis in progressive liver diseases | May 18, 2017 | Issued |
Array
(
[id] => 14747313
[patent_doc_number] => 20190256830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHOD FOR CELL-SPECIFICALLY CONTROLLING NUCLEASE
[patent_app_type] => utility
[patent_app_number] => 16/313328
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15806
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313328 | METHOD FOR CELL-SPECIFICALLY CONTROLLING NUCLEASE | May 17, 2017 | Abandoned |
Array
(
[id] => 14716219
[patent_doc_number] => 20190249173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/098658
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 206058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098658 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | May 2, 2017 | Abandoned |
| 15/584728 | Amplification of oligonucleotides containing non-standard nucleotides | May 1, 2017 | Abandoned |